Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I S Misko

Showing results (11-20 of 36) with videos related to

Pageof 4
Sort By:
The Journal of General Virology|February 1, 1991
Cytotoxic T lymphocyte discrimination between type A Epstein-Barr virus transformants is mapped to an immunodominant epitope in EBNA 3I S Misko, C Schmidt, D J Moss, et al.
Scandinavian Journal of Immunology|April 1, 1991
Oligopeptide induction of a secondary cytotoxic T-cell response to Epstein-Barr virus in vitroC Schmidt, S R Burrows, D J Moss, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 1, 1991
Nonresponsiveness to an immunodominant Epstein-Barr virus-encoded cytotoxic T-lymphocyte epitope in nuclear antigen 3A: implications for vaccine strategiesC Schmidt, S R Burrows, T B Sculley, et al.
Cellular Immunology|February 1, 1991
Composite response of naive T cells to stimulation with the autologous lymphoblastoid cell line is mediated by CD4 cytotoxic T cell clones and includes an Epstein-Barr virus-specific componentI S Misko, T B Sculley, C Schmidt, et al.
Immunology Letters|December 1, 1989
Interleukin-2 receptors in infectious mononucleosisC Schmidt, K Burman, D J Moss, et al.
Cellular Immunology|April 15, 1990
Patterns of reactivity of Epstein-Barr virus-specific T cells in A-type donor cultures after reactivation with autologous A- or B-type transformantsS R Burrows, I S Misko, T B Sculley, et al.
Clinical and Experimental Immunology|July 1, 1981
The distribution of a specific HLA-B27-associated cell surface component on the tissues of patients with ankylosing spondylitisK Alexander, C Edwards, I S Misko, et al.
Nature|February 25, 1988
Cytotoxic T-cell clones discriminate between A- and B-type Epstein-Barr virus transformantsD J Moss, I S Misko, S R Burrows, et al.
The Journal of Experimental Medicine|December 1, 1995
T cell receptor repertoire for a viral epitope in humans is diversified by tolerance to a background major histocompatibility complex antigenS R Burrows, S L Silins, D J Moss, et al.
The Journal of Infectious Diseases|October 23, 1997
Dominant cytotoxic T lymphocyte response to the immediate-early trans-activator protein, BZLF1, in persistent type A or B Epstein-Barr virus infectionS L Elliott, S J Pye, C Schmidt, et al.
Pageof 4

Showing results (11-20 of 36) with videos related to

Sort By:
Pageof 4
The Journal of General Virology|February 1, 1991
Cytotoxic T lymphocyte discrimination between type A Epstein-Barr virus transformants is mapped to an immunodominant epitope in EBNA 3I S Misko, C Schmidt, D J Moss, et al.
Scandinavian Journal of Immunology|April 1, 1991
Oligopeptide induction of a secondary cytotoxic T-cell response to Epstein-Barr virus in vitroC Schmidt, S R Burrows, D J Moss, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 1, 1991
Nonresponsiveness to an immunodominant Epstein-Barr virus-encoded cytotoxic T-lymphocyte epitope in nuclear antigen 3A: implications for vaccine strategiesC Schmidt, S R Burrows, T B Sculley, et al.
Cellular Immunology|February 1, 1991
Composite response of naive T cells to stimulation with the autologous lymphoblastoid cell line is mediated by CD4 cytotoxic T cell clones and includes an Epstein-Barr virus-specific componentI S Misko, T B Sculley, C Schmidt, et al.
Immunology Letters|December 1, 1989
Interleukin-2 receptors in infectious mononucleosisC Schmidt, K Burman, D J Moss, et al.
Cellular Immunology|April 15, 1990
Patterns of reactivity of Epstein-Barr virus-specific T cells in A-type donor cultures after reactivation with autologous A- or B-type transformantsS R Burrows, I S Misko, T B Sculley, et al.
Clinical and Experimental Immunology|July 1, 1981
The distribution of a specific HLA-B27-associated cell surface component on the tissues of patients with ankylosing spondylitisK Alexander, C Edwards, I S Misko, et al.
Nature|February 25, 1988
Cytotoxic T-cell clones discriminate between A- and B-type Epstein-Barr virus transformantsD J Moss, I S Misko, S R Burrows, et al.
The Journal of Experimental Medicine|December 1, 1995
T cell receptor repertoire for a viral epitope in humans is diversified by tolerance to a background major histocompatibility complex antigenS R Burrows, S L Silins, D J Moss, et al.
The Journal of Infectious Diseases|October 23, 1997
Dominant cytotoxic T lymphocyte response to the immediate-early trans-activator protein, BZLF1, in persistent type A or B Epstein-Barr virus infectionS L Elliott, S J Pye, C Schmidt, et al.
Pageof 4